MedPath

Respiratory Muscle Stretching in Chronic Obstructive Pulmonary Disease (COPD)

Phase 4
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT00935181
Lead Sponsor
Faculdade Evangelica do Parana
Brief Summary

Objective: The investigators studied the effects of respiratory muscle stretching in an 8-week pulmonary rehabilitation program. Methods: This was a simple-blind parallel controlled trial, conducted an out-patient clinic. Twenty six patients with COPD (mean age 68 ± 6 y, percent of predicted FEV1 47 ± 16) were randomized to either respiratory muscle stretching group plus exercise training (RMS), and exercise training group (Sham), in an 8-week exercise program that had 3 sessions per week. The investigators measured inspiratory and expiratory muscle strength (by maximal inspiratory and expiratory pressure - PIM and PEM), exercise capacity (by 6-minute walk distance), dyspnea and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Subjects between 40 and 75 years of age referred by a physician to the Pulmonary Rehabilitation Program
  • With a clinical and spirometric diagnosis of moderate to severe COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), in a stable condition (without exacerbations or infections for at least a month)
  • Former smokers
Exclusion Criteria
  • Patients with a known history of asthma, or severe and/or unstable heart disease
  • Any other pathological condition that could impair their physical activities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Inspiratory muscle strength2 hours
Secondary Outcome Measures
NameTimeMethod
Exercise capacity2 hours

Trial Locations

Locations (1)

Faculdade Evangelica do Paraná

🇧🇷

Curitiba, Paraná, Brazil

Faculdade Evangelica do Paraná
🇧🇷Curitiba, Paraná, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.